Aurinia Pharmaceuticals Inc.

No net buying or selling imbalance over the last 3 months

No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 5 CEO/CFO purchases over 12 months.

How to read this signal

Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.

JSON example

3-month balance

$0.00

0 buyers · 0 sellers

12-month purchases

$25,144,033

2 distinct insiders

12-month sales

$0.00

0 distinct insiders

Highlighted alerts

0 Rule 10b5-1 trades treated as informational

Buying cluster · 30 days

Fewer than three distinct buyers

CEO/CFO purchases · 12 months

5 executive purchases found

Get AUPH insider trades by API

The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.

Get your free API key

AUPH overview: breakout setup, X sentiment and insiders in one page →

Form 4 raw → Raspberry

The value is in what we do not call a signal.

The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.

Raw transactions

Everything returned by the filing

Voluntary view

P/S trades after deterministic checks

Administrative noise

Stored, never alerted

10b5-1

Shown as informational

SEC ownership XML facts

Code: S
Shares: 11,939
Price: $15.95
Footnotes: 2

Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Performance Stock Units (PSUs) related to the February 28, 2025 performance award. The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.95 to $15.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Raspberry interpretation

Informational — no alert

Reason: tax_withholding. The filing footnotes identify tax withholding.

Verify in SEC EDGAR

Recent transactions

Voluntary purchases and sales; administrative noise stays hidden.

15 transactions

TANG KEVIN

Chief Executive Officer

Jun 02, 2026

PurchaseAlert

Shares: 206,005
Price: $15.28
Value: $3,147,756

Date	Insider	Transaction	Shares	Price	Value	Reading
Jun 02, 2026	TANG KEVIN Chief Executive Officer	Purchase	206,005	$15.28	$3,147,756	Alert
Jun 01, 2026	TANG KEVIN Chief Executive Officer	Purchase	99	$15.34	$1,519	Alert
Jun 01, 2026	TANG KEVIN Chief Executive Officer	Purchase	343,521	$15.28	$5,249,001	Alert
May 29, 2026	TANG KEVIN Chief Executive Officer	Purchase	262,682	$15.31	$4,021,661	Alert
May 29, 2026	TANG KEVIN Chief Executive Officer	Purchase	2,299	$15.35	$35,290	Alert
Mar 03, 2026	TANG KEVIN Director	Purchase	184,208	$14.22	$2,619,438	Alert
Mar 02, 2026	TANG KEVIN Director	Purchase	115,792	$14.21	$1,645,404	Alert
Mar 02, 2026	TANG KEVIN Director	Purchase	83,561	$14.33	$1,197,429	Alert
Feb 27, 2026	TANG KEVIN Director	Purchase	1,600	$14.38	$23,008	Alert
Feb 27, 2026	TANG KEVIN Director	Purchase	214,839	$14.12	$3,033,527	Alert
Feb 27, 2026	TANG KEVIN Director	Purchase	300,000	$13.90	$4,170,000	Alert
Aug 05, 2025	TANG KEVIN Director	Purchase	200,000	$11.68	$2,336,000	Alert
Aug 04, 2025	TANG KEVIN Director	Purchase	100,000	$11.34	$1,134,000	Alert
Aug 01, 2025	Keenan Greg Chief Medical Officer	Sale	20,000	$10.50	$210,000	Alert
Aug 01, 2025	TANG KEVIN Director	Purchase	1,000,000	$10.12	$10,120,000	Alert